Cancer screening for bone marrow transplant survivors: a qualitative interview study
Summary
This study looks at how bone marrow and stem cell transplant survivors feel about cancer screening. We will interview people who had bone marrow or stem cell transplants. We will also talk to healthcare providers who care for these patients post-transplant. These conversations will help us to understand how to improve cancer screening.
This is important because bone marrow transplants are becoming more common. Hundreds of Albertans receive this treatment each year. Even though there are many survivors of bone marrow transplants, not everyone has access to survivorship care. These individuals also have a higher risk of cancer after their transplant. So, cancer screening is very important.
Eligibility
Eligible ages: 18 to 75
Inclusion criteria:
People who are eligible for this study
1) Live in Alberta
2) Have had bone marrow/stem cell transplant (also called BMT or hematopoietic cell transplant) as an adult (older than 18 years of age at time of treatment)
or
Are a healthcare provider who has cared for patients after bone marrow/stem cell transplant
(including hematologists, oncologist, primary care providers, and nurses)
Participate
Additional information
Contact information
To express interest in participating in tis study, please complete a short online survey so we can see whether you are eligible. [link will be provided when recruitment begins]
Principal investigator:
Dylan O'Sullivan
Clinical trial:
No
REB-ID:
HREBA.CC-26-0195